Journal
TRENDS IN IMMUNOLOGY
Volume 39, Issue 2, Pages 135-150Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.it.2017.10.002
Keywords
-
Categories
Funding
- NSF CAREER Award [1351688]
- National Multiple Sclerosis Society Award [RG-1501-02968]
- NIH [1R01AI062765, 1R01AI114496]
- Damon Runyon Foundation [DRR3415]
- Juvenile Diabetes Research Foundation [2-SRA-2016-319-S-B]
- NIH T32 Host-Pathogen Interaction Fellowship [AI089621]
- NIH/NCI Cancer Research Fellowship [43479]
- Div Of Chem, Bioeng, Env, & Transp Sys
- Directorate For Engineering [1351688] Funding Source: National Science Foundation
Ask authors/readers for more resources
Polymers, lipids, scaffolds, microneedles, and other biomaterials are rapidly emerging as technologies to improve the efficacy of vaccines against infectious disease and immunotherapies for cancer, autoimmunity, and transplantation. New studies are also providing insight into the interactions between these materials and the immune system. This insight can be exploited for more efficient design of vaccines and immunotherapies. Here, we describe recent advances made possible through the unique features of biomaterials, as well as the important questions for further study.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available